Stuart Redding

Sep 3, 2024 | nature.com | Raphael Wittenberg |Stuart Redding

AbstractThe Government of Kerala initiated a pilot screening programme for diabetic retinopathy in 16 Family Health Centres in Thiruvananthapuram district in 2019 in collaboration with the ORNATE India project. The evaluation of this pilot included a study of its costs and cost-effectiveness to inform decisions about extending the programme throughout Kerala.

Jan 24, 2024 | clinicalleader.com | Gregory J Privitera |Stuart Redding |Kerry Leyden

YPrime unveils a transformative brand focused on ‘Solving for Certainty’ in clinical trials. Experience the reimagined brand and explore the solutions that transform clinical research at www.yprime.com. The 3 Big Downsides To DCTsExamine three overlapping categories of concern when it comes to decentralized clinical trials: consent and selection, user experience, and comfort and privacy.

Sep 13, 2023 | clinicalleader.com | Stuart Redding |Kerry Leyden |Estelle Haenel

Webinar: How To Overcome Data Challenges And Experience The Benefits Of DCTs - Guidance For Patients, Sites, And SponsorsJoin us to discover how a data-led approach and innovative intuitive integration tools are resulting in closer connections to patients, consistent data flows, and faster insights. Learn how to transform the way you customize data management activities during collection and curation of data for a DCT clinical trial! Click here to learn more.

Apr 5, 2023 | clinicalleader.com | Mark Durivage |Craig Morgan |Stuart Redding |Kerry Leyden

FDA Seeks Comment On Considerations For Externally Controlled Trials For Drugs, Biologics   Guest Column | By Mark Durivage, Quality Systems Compliance LLC   On February 1, 2023, the FDA released a new guidance, "Considerations for the Design and Conduct of Externally Controlled Trials for Drug and Biological Products," for public comment. It provides recommendations to sponsors and investigators, addresses considerations for the design and analysis of such trials, and more.

Feb 17, 2023 | clinicalleader.com | Stuart Redding |Kerry Leyden

Article | February 17, 2023 By Stuart Redding and Kerry Leyden, Medical Research Network Decentralized clinical trials (DCTs), which allow patients to participate in clinical trials remotely, have grown exponentially in recent years due to advancements in data collection technology and the recent pandemic. When fully optimized, DCTs augment clinical sites by moving some visits out of a clinic or hospital and into a patient's home.